دورية أكاديمية
Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care.
| العنوان: | Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. |
|---|---|
| المؤلفون: | Blayney DW; Stanford Cancer Institute, Stanford University, Stanford, CA., Bariani G; Hospital Sirio Libanes, São Paulo, Brazil., Das D; Hematology Oncology at The Kirklin Clinic of University of Alabama, Birmingham, AL., Dawood S; Mediclinic City Hospital Dubai, Dubai, United Arab Emirates., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., De Guzman R; Manila Central University-FDTMF Hospital, Caloocan, Philippines., Martin SE; Medical Oncology Hematology Consultants, Wilmington, DE., O'Mahony D; Bon Secours Cork Cancer Centre, Cork, Ireland., Roach A; Teladoc Health, Washington, DC., Ruff P; University of the Witwatersrand, Johannesburg, South Africa., Sampaio C; Clinica AMO Salvador, Brazil., Sanchez JA; Hospital Escuela, University of Honduras, Tegucigalpa, Honduras., Vanderpuye V; National Center for Radiotherapy Oncology and Nuclear Medicine, Accra, Ghana., Kamal A; Duke University School of Medicine, Durham, NC., Hendricks C; Maryland Oncology Hematology, Bethesda, MD. |
| المصدر: | JCO global oncology [JCO Glob Oncol] 2021 Sep; Vol. 7, pp. 1513-1521. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Alexandria, VA : American Society of Clinical Oncology, [2020]- |
| مواضيع طبية MeSH: | COVID-19* , Neoplasms*/epidemiology , Neoplasms*/therapy, Delivery of Health Care ; Humans ; Pandemics ; Quality Improvement ; SARS-CoV-2 |
| مستخلص: | This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares perspectives from eight different countries, including Austria, Brazil, Ghana, Honduras, Ireland, the Philippines, South Africa, and the United Arab Emirates, which provide insight to their unique issues, challenges, and barriers to quality improvement in cancer care during the pandemic. These perspectives shed light on some key recommendations applicable on a global scale and focus on access to care, importance of expanding and developing new treatments for both COVID-19 and cancer, access to telemedicine, collecting and using COVID-19 and cancer registry data, establishing measures and guidelines to further enhance quality of care, and expanding communication among governments, health care systems, and health care providers. The impact of the COVID-19 pandemic on cancer care and quality improvement has been and will continue to be felt across the globe, but this report aims to share these experiences and learnings and to assist ASCO's international members and our global fight against the pandemic and cancer. Competing Interests: Giovanni BarianiConsulting or Advisory Role: LibbsResearch Funding: Mabxience, Merck Sharp & Dohme, Bristol Myers Squibb Shaheenah DawoodHonoraria: Novartis, Roche, Celgene, Janssen-Cilag, biocon, MSD, Pfizer, Bristol Myers Squibb, AbbVie, AstraZeneca, Caris Life SciencesConsulting or Advisory Role: MSD OncologySpeakers' Bureau: Pfizer, Roche/Genentech, AstraZenecaResearch Funding: MSD OncologyTravel, Accommodations, Expenses: Roche, MSD, Amgen, Pfizer, Bristol Myers Squibb Michael GnantEmployment: Sandoz (I)Honoraria: Amgen, Novartis, LillyConsulting or Advisory Role: Daiichi-Sankyo, Tolmar, LifeBrain, Lilly Roselle De GuzmanHonoraria: Novartis, Roche, AstraZeneca, Merck Serono, MSD Oncology, Boehringer IngelheimConsulting or Advisory Role: Roche, Novartis, AstraZeneca, Boehringer Ingelheim, AstraZenecaResearch Funding: Centus BiotherapeuticsTravel, Accommodations, Expenses: Hospira, Roche, Merck Sharp & Dohme, Eisai, Boehringer Ingelheim, AstraZeneca, Lilly¸ Novartis Deirdre O'MahonyConsulting or Advisory Role: Genomic Health/Exact SciencesTravel, Accommodations, Expenses: Roche, Novartis Ireland Ltd, Roche Paul RuffEmployment: TeladocStock and Other Ownership Interests: TeladocSpeakers' Bureau: Amgen, Mylan, MSDResearch Funding: Janssen Oncology, Roche, AstraZeneca, Novartis, PfizerTravel, Accommodations, Expenses: Merck Serono, MSD Oncology, Pfizer, Dr Reddy's Laboratories, AstraZeneca, Roche Arif KamalEmployment: Prepped Health, Acclivity Health, Private Diagnostic ClinicLeadership: Prepped Health, Acclivity HealthStock and Other Ownership Interests: Acclivity HealthConsulting or Advisory Role: Medtronic, Huron Therapeutics, New Century Health, Compassus, AstraZeneca, United Health Group¸ Janssen Oncology, Care4ward, United Health GroupTravel, Accommodations, Expenses: Janssen OncologyNo other potential conflicts of interest were reported. |
| References: | N Engl J Med. 2020 May 21;382(21):1969-1973. (PMID: 32227757) N Engl J Med. 2015 Apr 9;372(15):1381-4. (PMID: 25853741) N Engl J Med. 2020 Aug 27;383(9):801-803. (PMID: 32846057) JCO Glob Oncol. 2021 Jan;7:4-9. (PMID: 33405961) JAMA. 2021 Apr 6;325(13):1249-1250. (PMID: 33656519) Lancet Oncol. 2020 Aug;21(8):1023-1034. (PMID: 32702310) Cancer Cell. 2020 Nov 9;38(5):629-646. (PMID: 33049215) mBio. 2020 May 29;11(3):. (PMID: 32471830) |
| تواريخ الأحداث: | Date Created: 20211029 Date Completed: 20211103 Latest Revision: 20211105 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8563078 |
| DOI: | 10.1200/GO.21.00281 |
| PMID: | 34714666 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2687-8941 |
|---|---|
| DOI: | 10.1200/GO.21.00281 |